Bristol Myers Squibb (BMY) News Today $46.85 -0.66 (-1.38%) Closing price 03:59 PM EasternExtended Trading$46.92 +0.07 (+0.15%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Bristol Myers Squibb Down Today?Toggle Visibility of Why Is Bristol Myers Squibb Down Today?Bristol Myers Squibb (BMY) shares have risen as investors reacted to a series of positive pipeline updates, strategic partnerships and reaffirmed income appeal. Positive Sentiment: Investors named BMY among the 10 best and safe dividend stocks, highlighting its attractive yield and reliable income track record. Why Investors View Bristol-Myers Squibb (BMY) as a Safe Dividend Stock for Income Positive Sentiment: Phase 3 trial data for BMY’s pulmonary fibrosis therapy showed promising results, bolstering expectations for a new revenue driver. Bristol-Myers Squibb’s Promising Phase 3 Study on Pulmonary Fibrosis Drug Positive Sentiment: Early results from a new NSCLC study suggest potential breakthrough benefits, enhancing BMY’s oncology portfolio outlook. Bristol-Myers Squibb’s New NSCLC Study: A Potential Game-Changer? Positive Sentiment: BMY and Bain Capital launched a $300 million-backed spin-out to develop immunology drugs, allowing BMY to retain a 20% stake while sharing R&D risk. Bristol Myers, Bain Capital form new company to develop immunology drugs Positive Sentiment: BMY featured among four high-yield blue-chip pharma giants with significant total return potential, underlining its income and growth mix. 4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential Neutral Sentiment: Analysts preview BMY’s Q2 results alongside peers, noting growth from new launches may offset legacy portfolio declines. Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts? Neutral Sentiment: Investors are advised to wait and watch ahead of BMY’s Q2 earnings, as cost cuts and new drug rollouts may balance pipeline headwinds. Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings? Posted 2h agoAI Generated. May Contain Errors. BMY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Why Investors View Bristol‑Myers Squibb (BMY) as a Safe Dividend Stock for IncomeJuly 29 at 1:44 PM | msn.comBristol-Myers Squibb’s Promising Phase 3 Study on Pulmonary Fibrosis DrugJuly 29 at 12:40 PM | tipranks.comBanque Cantonale Vaudoise Makes New Investment in Bristol Myers Squibb Company (NYSE:BMY)July 29 at 7:14 AM | marketbeat.comPremier Fund Managers Ltd Cuts Position in Bristol Myers Squibb Company (NYSE:BMY)July 29 at 6:58 AM | marketbeat.comFederated Hermes Inc. Sells 1,101,066 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 29 at 6:48 AM | marketbeat.comMorningstar Investment Management LLC Has $683,000 Holdings in Bristol Myers Squibb Company (NYSE:BMY)July 29 at 6:25 AM | marketbeat.comPicton Mahoney Asset Management Lowers Stock Holdings in Bristol Myers Squibb Company (NYSE:BMY)July 29 at 5:29 AM | marketbeat.comMackenzie Financial Corp Buys 314,810 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 29 at 4:57 AM | marketbeat.comTCW Group Inc. Decreases Holdings in Bristol Myers Squibb Company (NYSE:BMY)July 29 at 4:48 AM | marketbeat.comBristol Myers, Bain Capital form new company to develop immunology drugsJuly 28 at 5:59 PM | reuters.comBristol Myers, Bain Capital form a new biopharmaceutical companyJuly 28 at 5:35 PM | msn.comBristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of PatientsJuly 28 at 5:06 PM | businesswire.comBristol Myers Squibb and Bain Capital Form New Immunology CompanyJuly 28 at 5:05 PM | wsj.comBristol-Myers Squibb’s New NSCLC Study: A Potential Game-Changer?July 28 at 12:57 PM | tipranks.comKinsale Capital Group Inc. Grows Position in Bristol Myers Squibb Company (NYSE:BMY)July 28 at 7:52 AM | marketbeat.comRidgewood Investments LLC Sells 7,758 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 28 at 7:47 AM | marketbeat.com4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialJuly 28 at 7:13 AM | 247wallst.comBristol Myers Squibb Company (NYSE:BMY) Shares Sold by Meridian Management Co.July 28 at 6:05 AM | marketbeat.comBristol-Myers Squibb Appoints New Chief Medical OfficerJuly 27 at 9:46 AM | theglobeandmail.comIntegrated Investment Consultants LLC Lowers Stock Position in Bristol Myers Squibb Company (NYSE:BMY)July 27 at 6:58 AM | marketbeat.comMarietta Investment Partners LLC Buys 66,978 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 27 at 6:49 AM | marketbeat.comBristol Myers Squibb Company (NYSE:BMY) Shares Acquired by Zurcher Kantonalbank Zurich CantonalbankJuly 27 at 6:25 AM | marketbeat.comFourThought Financial Partners LLC Sells 100,651 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 27 at 5:45 AM | marketbeat.comTD Asset Management Inc Sells 10,367 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 27 at 5:44 AM | marketbeat.comBristol Myers Squibb Company (NYSE:BMY) Shares Acquired by HB Wealth Management LLCJuly 27 at 5:34 AM | marketbeat.comMediolanum International Funds Ltd Buys 104,854 Shares of Bristol Myers Squibb Company (NYSE:BMY)July 27 at 5:17 AM | marketbeat.comTrilogy Capital Inc. Cuts Stake in Bristol Myers Squibb Company (NYSE:BMY)July 27 at 5:15 AM | marketbeat.comCetera Investment Advisers Boosts Stake in Bristol Myers Squibb Company (NYSE:BMY)July 27 at 4:47 AM | marketbeat.comBristol Myers Squibb Company (NYSE:BMY) Given Average Recommendation of "Hold" by BrokeragesJuly 27 at 2:09 AM | marketbeat.comSkandinaviska Enskilda Banken AB publ Has $80.05 Million Stake in Bristol Myers Squibb Company (NYSE:BMY)July 26 at 8:27 AM | marketbeat.comJ.P. Marvel Investment Advisors LLC Increases Stock Position in Bristol Myers Squibb Company (NYSE:BMY)July 26 at 8:26 AM | marketbeat.com6,150 Shares in Bristol Myers Squibb Company (NYSE:BMY) Acquired by Denver PWM LLCJuly 26 at 7:28 AM | marketbeat.comBristol Myers Squibb Company (NYSE:BMY) Shares Sold by Pacer Advisors Inc.July 26 at 7:15 AM | marketbeat.comAvantax Advisory Services Inc. Grows Stock Holdings in Bristol Myers Squibb Company (NYSE:BMY)July 26 at 4:51 AM | marketbeat.comBristol Myers Squibb Company (NYSE:BMY) Stake Increased by AE Wealth Management LLCJuly 26 at 4:16 AM | marketbeat.comBristol Myers Squibb taps Cristian Massacesi as CMOJuly 25, 2025 | msn.comBristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I DisorderJuly 25, 2025 | tipranks.comBristol-Myers Squibb’s Ozanimod Study: A Potential Game-Changer for Ulcerative Colitis TreatmentJuly 25, 2025 | tipranks.comBristol-Myers Squibb’s Promising SLE Treatment Study: Key Insights for InvestorsJuly 25, 2025 | tipranks.comBrookwood Investment Group LLC Acquires New Stake in Bristol Myers Squibb Company (NYSE:BMY)July 25, 2025 | marketbeat.comSound Shore Management Inc. CT Has $86.92 Million Stake in Bristol Myers Squibb Company (NYSE:BMY)July 25, 2025 | marketbeat.comCristian Massacesi, M.D., Joins Bristol Myers Squibb as Executive Vice President, Chief Medical Officer and Head of DevelopmentJuly 25, 2025 | businesswire.comAtria Investments Inc Reduces Stake in Bristol Myers Squibb Company (NYSE:BMY)July 25, 2025 | marketbeat.comLifeworks Advisors LLC Reduces Stake in Bristol Myers Squibb Company (NYSE:BMY)July 25, 2025 | marketbeat.comBristol Myers Squibb (NYSE:BMY) Stock Unloaded Rep. Jefferson ShreveJuly 24, 2025 | marketbeat.comQ1 Earnings Recap: Bristol-Myers Squibb (NYSE:BMY) Tops Branded Pharmaceuticals StocksJuly 24, 2025 | msn.comJim Cramer on Bristol-Myers: “Never Seen it This Cheap”July 24, 2025 | uk.finance.yahoo.comBristol-Myers Squibb Completes Key Study on Quality of Life in Cardiomyopathy PatientsJuly 24, 2025 | tipranks.comBristol-Myers Squibb’s New Study on BMS-986504: A Potential Game-Changer in Cancer Treatment?July 24, 2025 | tipranks.comBristol-Myers Squibb’s New Study: A Potential Game-Changer in Multiple Myeloma TreatmentJuly 24, 2025 | tipranks.com Get Bristol Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.071.07▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼5940▲BMY Articles Average Week Get Bristol Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Today Exelixis News Today Gilead Sciences News Today Moderna News Today Vertex Pharmaceuticals News Today AbbVie News Today Johnson & Johnson News Today Eli Lilly and Company News Today Merck & Co., Inc. News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol Myers Squibb Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.